These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 23996464

  • 1. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R, Zhu H, Chen Y, Li C, Li F, Shen Z, Tian J, Yu L, Xu B.
    Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
    [Abstract] [Full Text] [Related]

  • 2. Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma.
    Lee H, Kim SK, Kim YI, Kim TS, Kang SH, Park WS, Yun T, Eom HS.
    J Nucl Med; 2014 Feb; 55(2):216-22. PubMed ID: 24365650
    [Abstract] [Full Text] [Related]

  • 3. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M, Erba P, Volterrani D, Guidoccio F, Lazzeri E, Caramella D, Mariani G.
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [Abstract] [Full Text] [Related]

  • 4. Does partial volume corrected maximum SUV based on count recovery coefficient in 3D-PET/CT correlate with clinical aggressiveness of non-Hodgkin's lymphoma?
    Tsujikawa T, Otsuka H, Morita N, Saegusa H, Kobayashi M, Okazawa H, Nishitani H.
    Ann Nucl Med; 2008 Jan; 22(1):23-30. PubMed ID: 18250984
    [Abstract] [Full Text] [Related]

  • 5. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O.
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [Abstract] [Full Text] [Related]

  • 6. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [Abstract] [Full Text] [Related]

  • 7. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
    Mosavi F, Wassberg C, Selling J, Molin D, Ahlström H.
    Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
    Hoshi M, Takada J, Oebisu N, Hata K, Ieguchi M, Nakamura H.
    Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.
    Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, Campione A, Comino A, Biggi A.
    Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670
    [Abstract] [Full Text] [Related]

  • 10. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B, Wilson D, Laymon CM, Becker C, Mason NS, Bencherif B, Agarwal A, Luketich J, Landreneau R, Avril N.
    Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
    [Abstract] [Full Text] [Related]

  • 11. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S, Li G, Bural G, Alavi A.
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P, Bohn P, Edet-Sanson A, Salles A, Hapdey S, Gardin I, Ménard JF, Modzelewski R, Thiberville L, Dubray B.
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [Abstract] [Full Text] [Related]

  • 13. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS, Shon OJ, Han DS, Choi JH, Chun KA, Cho IH.
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [Abstract] [Full Text] [Related]

  • 14. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P, Köhler J, Wittsack HJ, Heusner TA, Buchbender C, Poeppel TD, Nensa F, Wetter A, Gauler T, Hartung V, Lanzman RS.
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M, Sharma R, D'Souza M, Jaimini A, Panwar P, Varshney R, Datta A, Kumar N, Garg G, Singh D, Grover RK, Mishra AK, Mondal A.
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [Abstract] [Full Text] [Related]

  • 16. Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma.
    Shinya T, Fujii S, Asakura S, Taniguchi T, Yoshio K, Alafate A, Sato S, Yoshino T, Kanazawa S.
    Ann Nucl Med; 2012 Oct; 26(8):616-21. PubMed ID: 22692457
    [Abstract] [Full Text] [Related]

  • 17. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
    Huang YE, Chen CF, Huang YJ, Konda SD, Appelbaum DE, Pu Y.
    Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
    [Abstract] [Full Text] [Related]

  • 18. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
    Minamimoto R, Mosci C, Jamali M, Barkhodari A, Habte F, Jackson T, Mittra E, Gambhir SS, Iagaru A.
    J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
    [Abstract] [Full Text] [Related]

  • 19. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF, Chang CC, Liu YC, Chang CS, Hsiao HH, Liu TC, Huang CT, Lin SF.
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.